The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
Study Type
OBSERVATIONAL
Enrollment
2,000
Cedars-Sinai Medical Center
Los Angeles, California, United States
RECRUITINGDeath
Death from any cause
Time frame: 1 month
Death
Death from any cause
Time frame: 1 year
Death
Death from any cause
Time frame: 2 years
Death
Death from any cause
Time frame: 3 years
Death
Death from any cause
Time frame: 4 years
Death
Death from any cause
Time frame: 5 years
Death from cardiac cause
Death from cardiac cause
Time frame: 1 month
Death from cardiac cause
Death from cardiac cause
Time frame: 1 year
Death from cardiac cause
Death from cardiac cause
Time frame: 2 years
Death from cardiac cause
Death from cardiac cause
Time frame: 3 years
Death from cardiac cause
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Death from cardiac cause
Time frame: 4 years
Death from cardiac cause
Death from cardiac cause
Time frame: 5 years
Stroke
disabling and non-disabling stroke
Time frame: 1 month
Stroke
disabling and non-disabling stroke
Time frame: 1 year
Stroke
disabling and non-disabling stroke
Time frame: 2 years
Stroke
disabling and non-disabling stroke
Time frame: 3 years
Stroke
disabling and non-disabling stroke
Time frame: 4 years
Stroke
disabling and non-disabling stroke
Time frame: 5 years
Repeat hospitalization
Number of hospitalizations
Time frame: 1 month
Repeat hospitalization
Number of hospitalizations
Time frame: 1 year
Repeat hospitalization
Number of hospitalizations
Time frame: 2 years
Repeat hospitalization
Number of hospitalizations
Time frame: 3 years
Repeat hospitalization
Number of hospitalizations
Time frame: 4 years
Repeat hospitalization
Number of hospitalizations
Time frame: 5 years
Bleeding
Life-threatening or major bleeding rate
Time frame: 1 month
Bleeding
Life-threatening or major bleeding rate
Time frame: 1 year
Bleeding
Life-threatening or major bleeding rate
Time frame: 2 years
Bleeding
Life-threatening or major bleeding rate
Time frame: 3 years
Bleeding
Life-threatening or major bleeding rate
Time frame: 4 years
Bleeding
Life-threatening or major bleeding rate
Time frame: 5 years
Vascular complication
Major vascular complication
Time frame: 1 month
Vascular complication
Major vascular complication
Time frame: 1 year
Vascular complication
Major vascular complication
Time frame: 2 years
Vascular complication
Major vascular complication
Time frame: 3 years
Vascular complication
Major vascular complication
Time frame: 4 years
Vascular complication
Major vascular complication
Time frame: 5 years
Acute kidney injury (stage 2 or 3)
Time frame: 1 month
Acute kidney injury (stage 2 or 3)
Time frame: 1 year
Acute kidney injury (stage 2 or 3)
Time frame: 2 years
Acute kidney injury (stage 2 or 3)
Time frame: 3 years
Acute kidney injury (stage 2 or 3)
Time frame: 4 years
Acute kidney injury (stage 2 or 3)
Time frame: 5 years
Prosthetic regurgitation by Doppler echocardiography
Time frame: at discharge
Prosthetic regurgitation by Doppler echocardiography
Time frame: 1 month
Prosthetic regurgitation by Doppler echocardiography
Time frame: 1 year
Prosthetic regurgitation by Doppler echocardiography
Time frame: 2 years
Prosthetic regurgitation by Doppler echocardiography
Time frame: 3 years
Prosthetic regurgitation by Doppler echocardiography
Time frame: 4 years
Prosthetic regurgitation by Doppler echocardiography
Time frame: 5 years
Mean aortic valve gradient by Doppler echocardiography
Time frame: 1 month
Mean aortic valve gradient by Doppler echocardiography
Time frame: 1 year
Mean aortic valve gradient by Doppler echocardiography
Time frame: 2 years
Mean aortic valve gradient by Doppler echocardiography
Time frame: 3 years
Mean aortic valve gradient by Doppler echocardiography
Time frame: 4 years
Mean aortic valve gradient by Doppler echocardiography
Time frame: 5 years